| Annual · values | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Gross Margin | 29.56% | 27.22% | -19.06% | -39.40% | 12.25% | -7.95% |
| Operating Margin | -24.68% | -43.06% | -118.76% | -134.22% | -107.21% | -257.00% |
| EBITDA Margin | -6.18% | -29.67% | -86.82% | 18.34% | -193.04% | -340.35% |
| Net Margin | -222.35% | -227.43% | -993.10% | -69.49% | -305.65% | -347.93% |
| Current Ratio | — | — | — | — | — | — |
| Quick Ratio | — | — | — | — | — | — |
| Debt / Equity | 0.67 | 1.10 | 1.09 | 0.44 | 0.46 | 0.11 |
| ROE | -122.76% | -135.02% | -435.45% | -9.13% | -46.13% | -26.80% |
| ROA | -65.18% | -51.97% | -135.65% | -5.90% | -24.49% | -20.23% |
| Asset Turnover | 0.29 | 0.23 | 0.14 | 0.08 | 0.08 | 0.06 |
| Book Value / Share | 4.53 | 6.69 | 11.28 | 63.67 | 67.07 | 102.39 |
Canopy Growth Corporation is a cannabis company that develops, cultivates, and sells medicinal and recreational cannabis, hemp, and cannabinoid-based products. Its portfolio includes brands serving adult-use, wellness, and medical consumers, along with products and devices across multiple categories. The company operates through segments such as Canada cannabis, international cannabis markets, Storz & Bickel, and This Works, reflecting a business model that spans plant-based products, vaporizers, and wellness offerings. Canopy Growth Corporation serves consumers, medical patients, and commercial partners in regulated markets, with a focus on cannabis product development, distribution, and brand differentiation. Headquartered in Smiths Falls, Ontario, Canopy Growth Corporation is positioned as a diversified participant in the global cannabis industry.